Company Monitoring Page for Bayer

latest headlines for company on cafepharma

July Brings Layoffs, Job Creation for the Life Sciences
BioSpace
Wed, 08/3/22 - 09:32 pm
Tags:
layoffs, hirings, Astellas, Pfizer, Eikon Therapeutics, Bayer, Avadel Pharma, Heron Therapeutics, Adverum Biotechnologies, Biogen, Eisai, X4 Pharmaceuticals, Assembly Biosciences
Bayer-Ionis' anti-thrombotic med doesn't increase bleeding in phase 2, setting stage for a new type of anticoagulant
Fierce Biotech
Thu, 07/28/22 - 05:54 pm
Tags:
Bayer, Ionis Pharmaceuticals, kidney disease, clinical trials, fesomersen
In $500M deal, Bayer offloads testosterone deficiency drug Nebido to Grünenthal
Fierce Pharma
Thu, 07/14/22 - 07:58 pm
Tags:
Bayer, testosterone, hypogonadism, Grunenthal
Follow-Up Data on Bayer’s Larotrectinib Hints at Potentially Curative Impact
BioSpace
Thu, 07/7/22 - 10:29 am
Tags:
Bayer, larotrectinib, cancer, ASCO 2022
Bayer AG opens Kendall Square research center focused on cancer
Boston Globe, MA
Fri, 07/1/22 - 09:46 am
Tags:
Bayer, Kendall Square, R&D, Boston, innovation, cancer, oncology
Move over Medtech, Pharma Is Embracing AI, Too!
Medical Devices and Diagnostics Industry
Wed, 06/29/22 - 05:29 pm
Tags:
Medtech, Merck, Bayer, machine learning, artificial intelligence
ADA: Bayer builds its case for potential kidney disease blockbuster Kerendia
Fierce Pharma
Tue, 06/7/22 - 10:13 am
Tags:
ADA, diabetes, Bayer, chronic kidney disease, Kerendia
Bayer pulls plug on $670M CAR-T cell therapy pact with Atara in wake of patient death
Fierce Biotech
Fri, 05/20/22 - 10:22 am
Tags:
Bayer, Atara Biotherapeutics, patient death, CAR-T, clinical trials
Bayer's farming business drives Q1 earnings beat
Yahoo/Reuters
Tue, 05/10/22 - 10:53 am
Tags:
Bayer, earnings
Aiming to treat Parkinson’s by replacing neurons, Aspen Neuroscience nabs $147M
MedCity News
Mon, 05/9/22 - 11:22 pm
Tags:
Aspen Neuro, Parkinson's Disease, stem cells, Bayer, cell therapy
Bayer's Nubeqa one step closer to blockbuster status thanks to FDA priority review in potential new use
Fierce Pharma
Tue, 05/3/22 - 10:48 pm
Tags:
Bayer, Nubeqa, prostate cancer
Bayer nabs yet another oncology leader from GSK to bolster cancer efforts
Fierce Biotech
Fri, 04/22/22 - 10:34 am
Tags:
Bayer, GSK, oncology
First-quarter biotech risers work hard for the win
EP Vantage
Thu, 04/21/22 - 10:32 am
Tags:
biotech, AbbVie, Bayer, Ipsen, Lantheus Medical
ACC: Bayer’s Kerendia cuts cardio and kidney complications in high-risk patients
Fierce Pharma
Mon, 04/4/22 - 11:20 pm
Tags:
Bayer, ACC, kidney disease, Kerendia
Running behind Bristol Myers and J&J, Bayer inches forward in the next-gen blood thinner race
Endpoints
Mon, 04/4/22 - 10:56 am
Tags:
Bayer, bloodthinners, asundexian, clinical trials, Eliquis, Bristol Myers Squibb, JNJ
Bayer reloads Leaps with €1.3 billion to step up investments in biotech innovation
MedCity News
Mon, 04/4/22 - 10:19 am
Tags:
Bayer, Leaps by Bayer, innovation, artificial intelligence, gene therapy, cell therapy, funding
A Bayer partner slims down, trimming R&D and enacting layoffs, to better focus on the pair's prostate cancer work
Endpoints
Thu, 03/24/22 - 10:53 am
Tags:
Orion, Bayer, prostate cancer, layoffs, R&D
Bayer-backed Affini-T snags $175M to enter increasingly crowded KRAS-cancer field
Fierce Biotech
Tue, 03/22/22 - 10:09 am
Tags:
Affini-T Therapeutics, venture capital, Bayer, KRAS
Steep drop in medical device reports on Bayer's Essure in 2021, FDA data show
Medtech Dive
Wed, 03/16/22 - 10:28 am
Tags:
devices, Medtech, Bayer, Essure, contraceptives
Amid inflation spike, execs at J&J, Bayer, GSK and more talk higher costs—and what it means for profits
Fierce Pharma
Fri, 03/11/22 - 11:06 am
Tags:
inflation, JNJ, Bayer, GSK, Viatris

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.